Greten, T. F., Hrones, D. M., Monge, C., Skorupan, N., Kleiner, D. E., Wood, B., Redd, B. (2026). A phase I/II study of CDX-1140, a CD40 agonist, in combination with capecitabine and oxaliplatin (CAPOX) and pembrolizumab in subjects with biliary tract carcinoma: Phase 1 results.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4129